Center-Authored Papers

Filters: Author is Oehler, Vivian G  [Clear All Filters]
2016
Bajaj J, Konuma T, Lytle NK, Kwon HY, Ablack JN, Cantor JM, Rizzieri D, Chuah C, Oehler VG, Broome EH et al..  2016.  CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia.. Cancer cell. 30(5):792-805. Abstract
Soma L, Oehler VG, Ding C, Cherian S.  2016.  Small, abnormal B lymphoid blast populations in Chronic Myelogenous Leukemia at diagnosis: Does this finding indicate an accelerated course? Cytometry. Part B, Clinical cytometry. Abstract
Ramamurthy R, Hughes M, Morris V, Bolouri H, Gerbing RB, Wang Y-C, Loken MR, Raimondi SC, Hirsch BA, Gamis AS et al..  2016.  miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.. Pediatric blood & cancer. Abstract
Brehme M, Koschmieder S, Montazeri M, Copland M, Oehler VG, Radich JP, Brümmendorf TH, Schuppert A.  2016.  Combined Population Dynamics and Entropy Modelling Supports Patient Stratification in Chronic Myeloid Leukemia.. Scientific reports. 6:24057. Abstract
2015
Kwon HY, Bajaj J, Ito T, Blevins A, Konuma T, Weeks J, Lytle NK, Koechlein CS, Rizzieri D, Chuah C et al..  2015.  Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia.. Cell stem cell. Abstract
Morris VA, Cummings CL, Korb B, Boaglio S, Oehler VG.  2015.  Deregulated KLF4 expression in myeloid leukemias alters cell proliferation and differentiation through microRNA and gene targets.. Molecular and cellular biology. Abstract
Ostronoff F, Othus M, Lazenby M, Estey E, Appelbaum FR, Evans A, Godwin J, Gilkes A, Kopecky KJ, Burnett A et al..  2015.  Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(10):1157-64. Abstract
Martinelli G, Oehler VG, Papayannidis C, Courtney R, Shaik NM, Zhang X, O'Connell A, McLachlan KR, Zheng X, Radich J et al..  2015.  Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study. The Lancet Haematology. 2(8):e339-e346. Abstract
2014
Zimdahl B, Ito T, Blevins A, Bajaj J, Konuma T, Weeks J, Koechlein CS, Kwon HY, Arami O, Rizzieri D et al..  2014.  Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia.. Nature genetics. Abstract
2013
Morris VA, Zhang A, Yang T, Stirewalt DL, Ramamurthy R, Meshinchi S, Oehler VG.  2013.  MicroRNA-150 Expression Induces Myeloid Differentiation of Human Acute Leukemia Cells and Normal Hematopoietic Progenitors.. PloS one. 8(9):e75815. Abstract
Pogosova-Agadjanyan EL, Kopecky KJ, Ostronoff F, Appelbaum FR, Godwin J, Lee H, List AF, May JJ, Oehler VG, Petersdorf S et al..  2013.  The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemia.. PloS one. 8(8):e70812. Abstract
Oehler VG.  2013.  Update on current monitoring recommendations in chronic myeloid leukemia: practical points for clinical practice.. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2013:176-83. Abstract
2011
Ho PA, Kopecky KJ, Alonzo TA, Gerbing RB, Miller KL, Kuhn J, Zeng R, Ries RE, Raimondi SC, Hirsch BA et al..  2011.  Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric/adult AML: a report from the Children's Oncology Group and SWOG.. Blood. 118(17):4561-6. Abstract
Champagne MA, Fu CH, Chang M, Chen H, Gerbing RB, Alonzo TA, Cooley LD, Heerema NA, Oehler VG, Wood C et al..  2011.  Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology Group.. Pediatric blood & cancer. 57(1):56-62. Abstract
2010
Ho PA, Alonzo TA, Kopecky KJ, Miller KL, Kuhn J, Zeng R, Gerbing RB, Raimondi SC, Hirsch BA, Oehler VG et al..  2010.  Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 24(5):909-13. Abstract
Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE, Zhao C, Lagoo A, Gerrard G, Foroni L et al..  2010.  Regulation of myeloid leukaemia by the cell-fate determinant Musashi.. Nature. 466(7307):765-8. Abstract
2009
Oehler VG, Yeung KY, Choi YE, Bumgarner RE, Raftery AE, Radich JP.  2009.  The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data.. Blood. 114(15):3292-8. Abstract
Oehler VG, Guthrie KA, Cummings CL, Sabo K, Wood BL, Gooley TA, Yang T, Epping MT, Shou Y, Pogosova-Agadjanyan E et al..  2009.  The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.. Blood. 114(15):3299-308. Abstract